Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (50.0%)Phase 1
1 (25.0%)phase_1_2
1 (25.0%)Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Novalead Pharma Private Limited
- Target Recruit Count
- 176
- Registration Number
- NCT03998436
- Locations
- 🇮🇳
Yalamanchi Hospita, Vijayawada, Andhra Pradesh, India
🇮🇳M.S. Ramaiah Medical College and Hospital, Bangalore, Karnataka, India
🇮🇳Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Drug: Placebo gel
- First Posted Date
- 2010-04-30
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Novalead Pharma Private Limited
- Target Recruit Count
- 44
- Registration Number
- NCT01113515
- Locations
- 🇺🇸
VA New England Health Care Division, Providence, Rhode Island, United States
🇮🇳S.L. Raheja Hospital, Mumbai, Maharashtra, India
🇮🇳Deenanath Mangeshkar Hospital & Research Center, Pune, Maharashtra, India
News
No news found